Erythroid Neoplasm — Trials

Erythroid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

260 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 25
Ph III recruiting: 7
Growth YoY: —
Industry share: 48%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (50)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02386800	CINC424A2X01B Rollover Protocol	active not recruiting	Phase 4	279	Novartis PharmaceuticalsINDUSTRY	25	Aug 20, 2026	clinicaltrials
NCT05853458	Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors(HU-F-AIM)	terminated	Phase 4	76	Novartis PharmaceuticalsINDUSTRY	1	Aug 18, 2026	clinicaltrials